Plethico Pharmaceuticals' Q4 net profit at Rs 55 cr; stock up

MUMBAI: Plethico Pharmaceuticals reported consolidated net profit of Rs 55.2 crores for quarter ended March 2011 as against Rs 26.5 crores in the corresponding quarter a year ago. Consolidated revenues stood at Rs 354 crore and EBITDA margin stood at 20.1% as against 14.3% for Q4 FY 10.

The stock was at Rs 342.05, up 0.15 per cent on the NSE. It touched a high of Rs 348 and low of Rs 342.05 in trade so far.